JP2019532069A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019532069A5 JP2019532069A5 JP2019520031A JP2019520031A JP2019532069A5 JP 2019532069 A5 JP2019532069 A5 JP 2019532069A5 JP 2019520031 A JP2019520031 A JP 2019520031A JP 2019520031 A JP2019520031 A JP 2019520031A JP 2019532069 A5 JP2019532069 A5 JP 2019532069A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutical composition
- compound according
- disease
- disorder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CCCCCCCCCCCCCCC[C@@](*)N=CC*C(CCCCCCCC=CC*=CCCCCC)=O Chemical compound CCCCCCCCCCCCCCC[C@@](*)N=CC*C(CCCCCCCC=CC*=CCCCCC)=O 0.000 description 4
- OSNAOIJEFJLEPS-UHFFFAOYSA-N CCCCCCCCCCCCCCCC(NCCOC(CCC(OCC(CO)O)=O)=O)=O Chemical compound CCCCCCCCCCCCCCCC(NCCOC(CCC(OCC(CO)O)=O)=O)=O OSNAOIJEFJLEPS-UHFFFAOYSA-N 0.000 description 1
- GUCQUFPZDATELC-UHFFFAOYSA-N CCCCCCCCCCCCCCCC(NCCOC(CCC(OCC(COC(CCC)=O)OC(CCC)=O)=O)=O)=O Chemical compound CCCCCCCCCCCCCCCC(NCCOC(CCC(OCC(COC(CCC)=O)OC(CCC)=O)=O)=O)=O GUCQUFPZDATELC-UHFFFAOYSA-N 0.000 description 1
- SAVIEPORGSLYFE-WQQZHNEZSA-N CCCCCCCCCCCCCCCC(NCCOC(CCC(OC[C@H]([C@H]([C@@H]1O)O)O[C@@]1(CO)O[C@H]([C@@H]([C@H]1O)O)O[C@H](CO)[C@H]1O)=O)=O)=O Chemical compound CCCCCCCCCCCCCCCC(NCCOC(CCC(OC[C@H]([C@H]([C@@H]1O)O)O[C@@]1(CO)O[C@H]([C@@H]([C@H]1O)O)O[C@H](CO)[C@H]1O)=O)=O)=O SAVIEPORGSLYFE-WQQZHNEZSA-N 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662407796P | 2016-10-13 | 2016-10-13 | |
| US62/407,796 | 2016-10-13 | ||
| US201762517344P | 2017-06-09 | 2017-06-09 | |
| US62/517,344 | 2017-06-09 | ||
| PCT/US2017/056353 WO2018071679A1 (en) | 2016-10-13 | 2017-10-12 | N-acylethanolamide derivatives and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019532069A JP2019532069A (ja) | 2019-11-07 |
| JP2019532069A5 true JP2019532069A5 (OSRAM) | 2020-11-19 |
| JP7041673B2 JP7041673B2 (ja) | 2022-03-24 |
Family
ID=61906457
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019520031A Expired - Fee Related JP7041673B2 (ja) | 2016-10-13 | 2017-10-12 | Ｎ－アシルエタノールアミド誘導体およびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US10933037B2 (OSRAM) |
| EP (1) | EP3526215A4 (OSRAM) |
| JP (1) | JP7041673B2 (OSRAM) |
| CN (1) | CN110023308A (OSRAM) |
| AU (2) | AU2017341769B2 (OSRAM) |
| CA (1) | CA3040258A1 (OSRAM) |
| WO (1) | WO2018071679A1 (OSRAM) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3040258A1 (en) * | 2016-10-13 | 2018-04-19 | Carnot, Llc | N-acylethanolamide derivatives and uses thereof |
| WO2019213333A1 (en) * | 2018-05-04 | 2019-11-07 | Carnot2, Llc | Combination therapies with edaravone and prodrugs of edaravone that are orally bioavailable and have altered pharmacokinetic properties |
| WO2019213335A1 (en) * | 2018-05-04 | 2019-11-07 | Carnot2, Llc | Orally bioavailable prodrugs of edaravone with altered pharmacokinetic properties and methods of use thereof |
| MX2021009328A (es) * | 2019-02-21 | 2021-11-12 | Univ Claude Bernard Lyon | Vectores moleculares estructurados y usos de los mismos. |
| GB202103884D0 (en) | 2021-03-19 | 2021-05-05 | Eliem Therapeutics Uk Ltd | Novel process |
| CN113304683B (zh) * | 2021-06-17 | 2022-12-13 | 江南大学 | 葡糖酰胺封端聚醚型表面活性剂、其制备方法及应用 |
| WO2025185743A1 (en) * | 2024-03-07 | 2025-09-12 | Centre for Chinese Herbal Medicine Drug Development Limited | N-oleoylethanolamide and eubacterium rectale for use in treating diarrhea-predominant irritable bowel syndrome |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2440361A (en) * | 1947-08-12 | 1948-04-27 | Lilly Co Eli | Process and culture media for the production of penicillin |
| DE4127471A1 (de) * | 1991-08-20 | 1993-02-25 | Henkel Kgaa | Verwendung von aminoalkanolamidestern als verarbeitungshilfsmittel fuer thermoplastische kunststoffe |
| IT1271623B (it) * | 1994-03-21 | 1997-06-04 | Lifegroup Spa | N-acilderivati di aminoalcoli con acidi monocarbossilici e bicarbossilici con attivita' neuroprotettiva nelle patologie neurologiche correlate ad eccitotossicita' |
| IT1271266B (it) * | 1994-12-14 | 1997-05-27 | Valle Francesco Della | Impiego terapeutico di ammidi di acidi mono e bicarbossilici con amminoalcoli,selettivamente attive sul recettore periferico dei cannabinoidi |
| JP4015710B2 (ja) * | 1995-05-31 | 2007-11-28 | 生化学工業株式会社 | 新規擬似糖脂質 |
| NZ336538A (en) * | 1996-10-15 | 2001-11-30 | Liposome Co Inc | N-acyl phosphatidylethanolamine-mediated liposomal drug delivery |
| DE69932187T2 (de) | 1999-03-11 | 2007-05-24 | Ardenia Investments Ltd. | Verbindungen für krebs-therapie |
| DE69909137T2 (de) | 1999-03-16 | 2004-05-19 | Ardenia Investments Ltd. | Polyungesättigte Fettsäurederivate und deren Verwendung in der Krebsbehandlung |
| US7090903B2 (en) * | 2002-10-07 | 2006-08-15 | Konica Corporation | Ink-jet recording sheet |
| JP2004268437A (ja) | 2003-03-10 | 2004-09-30 | Konica Minolta Holdings Inc | インクジェット記録用紙 |
| FR2925491B1 (fr) * | 2007-12-19 | 2010-09-03 | Oz Biosciences Sas | Nouvelle classe de lipides cationiques pour le transport d'agents actifs dans les cellules |
| ITMI20122127A1 (it) | 2012-12-13 | 2014-06-14 | Epitech Group Srl | Derivati polietilenglicolici di palmitoiletanolammide e aciletanolammidi analoghe |
| WO2014197880A1 (en) | 2013-06-07 | 2014-12-11 | Loma Linda University | Dietary omega-3 fatty acid derived glycerophospholipids to treat neuropathic pain |
| CA3040258A1 (en) | 2016-10-13 | 2018-04-19 | Carnot, Llc | N-acylethanolamide derivatives and uses thereof |
-
2017
- 2017-10-12 CA CA3040258A patent/CA3040258A1/en not_active Abandoned
- 2017-10-12 EP EP17860455.9A patent/EP3526215A4/en not_active Withdrawn
- 2017-10-12 CN CN201780074079.4A patent/CN110023308A/zh active Pending
- 2017-10-12 WO PCT/US2017/056353 patent/WO2018071679A1/en not_active Ceased
- 2017-10-12 AU AU2017341769A patent/AU2017341769B2/en not_active Ceased
- 2017-10-12 JP JP2019520031A patent/JP7041673B2/ja not_active Expired - Fee Related
- 2017-10-12 US US16/349,548 patent/US10933037B2/en not_active Expired - Fee Related
-
2020
- 2020-12-09 US US17/116,414 patent/US11547681B2/en active Active
-
2021
- 2021-11-26 AU AU2021273632A patent/AU2021273632A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019532069A5 (OSRAM) | ||
| JP7041673B2 (ja) | Ｎ－アシルエタノールアミド誘導体およびその使用 | |
| US20130202629A1 (en) | Uses of phospholipid conjugates of synthetic tlr7 agonists | |
| US11629163B2 (en) | Methods of synthesizing nicotinamide riboside | |
| US8049038B2 (en) | Carnitine conjugates of adamantanamines derivatives as dual prodrugs for various uses | |
| CN109721580B (zh) | 3-苯基-7,8-脱氢葡萄藤戊素衍生物、其制法和药物组合物与用途 | |
| US20040053881A1 (en) | Adenosine derivatives and use thereof | |
| CN102918051B (zh) | N6-(甲基二茂铁)喹唑啉-2,4,6-三胺(h2)和其衍生物,以及用作抗菌剂、抗寄生虫剂、抗原虫和抗利什曼虫剂的药物前体 | |
| CN109721579B (zh) | 7,8-脱氢葡萄藤戊素衍生物、其制法和药物组合物与用途 | |
| EA037149B1 (ru) | Биодоступные полиамины | |
| CN101541717B (zh) | 一种反式苯丙烯酸衍生物及其制备方法和应用 | |
| CN105163732A (zh) | 用于治疗眼科疾病和病症的方法 | |
| JPH09510467A (ja) | 興奮毒性に関連した神経病理学的な状態において神経保護作用を行う薬剤の製造におけるアミノアルコールのｎ−アシル誘導体の使用 | |
| CN105330708B (zh) | 延胡索乙素衍生物及其制备方法、用途 | |
| JP2022514084A (ja) | ６，８－ビス－ベンジルチオ－オクタン酸を使用する経口療法 | |
| US20250281491A1 (en) | Dual functioning immune modulating compounds, formulations, and uses thereof | |
| WO2011147254A1 (zh) | 苯丁酰基姜黄素衍生物及其在制备抗肿瘤药物中的应用 | |
| CN103037842B (zh) | 药物化合物 | |
| JP2019524654A (ja) | 新しいタイプのタキサン化合物、その製造方法および適用 | |
| TW202114650A (zh) | 6,8-雙(苄基磺醯基)辛酸之氘化衍生物 | |
| WO2022089600A1 (zh) | 黄酮苷-有机胺类抗微生物剂复盐化合物及其制备方法和应用 | |
| TW202114651A (zh) | 用於治療癌症之方法及含有４，６—雙（苄硫基）己酸之藥物組成物 | |
| JP2023511432A (ja) | ７－デアセチル－フォルスコリンとｐｖｐの複合体 | |
| CA2421067A1 (en) | Adenosine derivatives and use thereof | |
| CN109705120A (zh) | 一类咪唑并[1,2-a]吡啶化合物及其制备方法和用途 |